监测,流行病学和最终结果数据显示,在美国妇女中,远期乳腺癌的发病率在增加
R Edward Hendrick1, Debra L Monticciolo1
1From the Department of Radiology, University of Colorado School of Medicine, 12401 E 17th Ave, Aurora, CO 80045 (R.E.H.); and Foundation for Imaging Research and Education, Temple, Tex (D.L.M.).
Radiology
|December 10, 2024
概括
远期乳腺癌发病率在所有年龄段的美国女性中都在上升,年轻女性和少数民族人口的显着增加. COVID-19大流行也影响了检测率,特别是在老年少数民族妇女中.
科学领域:
- 在瘤学瘤学.
- 流行病学 流行病学
- 公共卫生 公共卫生
背景情况:
- 远期 (转移性) 乳腺癌在初始呈现时的发病率在40岁以下的美国女性中显著增加.
- 之前的报告表明,老年女性没有明显的趋势,需要更新分析.
- 了解这些趋势对于公共卫生干预和资源分配至关重要.
研究的目的:
- 调查远期乳腺癌发病率的当代趋势.
- 分析包括COVID-19流行年 (2020-2021) 在内的数据.
- 为了检查美国妇女的年龄组和种族/种族的发病率.
主要方法:
- 追溯分析2004年至2021年的监测,流行病学和最终结果 (SEER 22) 数据.
- 每年包括71至8000万名妇女.
- 用于评估特定阶段发病率趋势的joinpoint软件.
主要成果:
- 远期乳腺癌的总体发病率每年增加1.16% (2004-2021年).
- 在20-39岁的女性 (2.91%的APC) 和75岁以上 (1.44%的APC) 中观察到显著增加.
- 与白人女性相比,亚洲,黑人和西班牙裔女性的发病率更高;COVID-19影响了检测,特别是在少数群体中.
结论:
- 远期乳腺癌发病率在美国女性总体和多个年龄组显著增加.
- 种族和民族差异仍然存在,亚洲,黑人,西班牙裔和美洲原住民女性的比例更高.
- 调查结果强调,迫切需要有针对性的查和干预策略.
相关概念视频
02:07Tumor Progression
6.2K
Tumor progression is a phenomenon where the pre-formed tumor acquires successive mutations to become clinically more aggressive and malignant. In the 1950s, Foulds first described the stepwise progression of cancer cells through successive stages.
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
6.2K
01:21Cancer Survival Analysis
328
Cancer survival analysis focuses on quantifying and interpreting the time from a key starting point, such as diagnosis or the initiation of treatment, to a specific endpoint, such as remission or death. This analysis provides critical insights into treatment effectiveness and factors that influence patient outcomes, helping to shape clinical decisions and guide prognostic evaluations. A cornerstone of oncology research, survival analysis tackles the challenges of skewed, non-normally...
328